Encompass Health Corporation

XNYSHealth care

Last traded price · USD

$141.05

+0.01%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 14:39 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $141.03
Volume: 4
Day's high: —
Day's low: —

In brief

Encompass Health Corporation is a health care company listed on the New York Stock Exchange, valued at about $13.87B.
Its shares closed at $141.03 on 4 Nov 2026, up 20.4% over the past year.
From India you can buy EHC in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Encompass Health Corporation (EHC) shares from India?

Yes. Indian residents can invest in the US stock market under the Reserve Bank of India's Liberalised Remittance Scheme (LRS), which lets a resident individual remit up to USD 250,000 per financial year, across all permitted purposes combined. US-listed stocks and ETFs are a permitted investment under the LRS. You are solely responsible for ensuring your remittances comply with the LRS annual limit, the applicable Tax Collected at Source (TCS) rules, and all reporting requirements, including Schedule FA in your income-tax return.

Do I need the price of a whole EHC share to invest?

Yes. You can buy fractional shares, which lets you invest a fixed rupee/dollar amount even in high-priced stocks. For example, if one share trades at USD 1,000 and you invest USD 100, you receive 0.1 of a share.

How much can I invest in US stocks in a year?

Under the LRS, an Indian resident can remit up to USD 250,000 per financial year (April to March) across all permitted purposes combined, from their own funds. This is a per-individual limit set by the RBI.

Can I trade EHC options or futures?

No. Under RBI / FEMA rules, the LRS does not permit margin trading or speculative instruments such as futures, options, or other derivatives. Your US account is a cash account, not a derivatives and margin account.

Insights

Quotes run fifteen minutes behind.

Set a 52-week high on 4 Nov 2026
Closed at $141.03 on 4 Nov 2026: 0.7% below the 52-week high of $141.99 (4 Nov 2026) and 52.0% above the low of $92.77 (3 Feb 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026
Ahead of SPY, behind its sector fund XLV over 1 year
1 month: +13.1% (SPY −1.6%, XLV +13.5%). 3 months: +27.2% (SPY −0.4%, XLV +15.5%). 1 year: +20.4% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: EHC, SPY and XLV · as of 4 Nov 2026
Volume 2.1× its 30-session average on 29 Oct 2026
29 Oct 2026 volume of 2.2M shares was 2.1× the average of the 30 sessions before it (1.0M), as the price rose 7.7%. SPY traded 1.0× its own average that session.
Daily volume against a 30-session baseline · as of 29 Oct 2026
Above its 50- and 200-day averages
The 4 Nov 2026 close of $141.03 was 13.8% above its 50-day average ($123.88) and 27.5% above its 200-day average ($110.60). It has closed above the 200-day for 86 sessions, since 7 Jul 2026. The 50-day average crossed above the 200-day on 7 Aug 2026, 62 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
RSI(14) at 71.3, 70 or above
The 14-session relative strength index closed at 71.3 on 4 Nov 2026, its 1st session at 70 or above. By convention a reading of 70 or above is called overbought and 30 or below oversold.
Daily closes, split-adjusted; Wilder's 14-session RSI · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month+13.1%

6 months+34.3%

1 year+20.4%

5 years+129.4%

Newswire

About

Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals, which is the company's sole segment. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. The company's inpatient rehabilitation hospitals provide a higher level of rehabilitative care to patients who are recovering from conditions such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.

Website

Notable moves

August 6, 2026
+12.55%
April 25, 2025
+11.79%
July 1, 2022
−16.97%

Newswire

About

Website

Notable moves

August 6, 2026
+12.55%
April 25, 2025
+11.79%
July 1, 2022
−16.97%

Encompass Health Corporation

XNYSHealth care

Last traded price · USD

$141.05

+0.01%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 14:39 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $141.03
Volume: 4
Day's high: —
Day's low: —

In brief

Encompass Health Corporation is a health care company listed on the New York Stock Exchange, valued at about $13.87B.
Its shares closed at $141.03 on 4 Nov 2026, up 20.4% over the past year.
From India you can buy EHC in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Encompass Health Corporation (EHC) shares from India?

Do I need the price of a whole EHC share to invest?

How much can I invest in US stocks in a year?

Can I trade EHC options or futures?

Insights

Quotes run fifteen minutes behind.

Set a 52-week high on 4 Nov 2026
Closed at $141.03 on 4 Nov 2026: 0.7% below the 52-week high of $141.99 (4 Nov 2026) and 52.0% above the low of $92.77 (3 Feb 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026
Ahead of SPY, behind its sector fund XLV over 1 year
1 month: +13.1% (SPY −1.6%, XLV +13.5%). 3 months: +27.2% (SPY −0.4%, XLV +15.5%). 1 year: +20.4% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: EHC, SPY and XLV · as of 4 Nov 2026
Volume 2.1× its 30-session average on 29 Oct 2026
29 Oct 2026 volume of 2.2M shares was 2.1× the average of the 30 sessions before it (1.0M), as the price rose 7.7%. SPY traded 1.0× its own average that session.
Daily volume against a 30-session baseline · as of 29 Oct 2026
Above its 50- and 200-day averages
The 4 Nov 2026 close of $141.03 was 13.8% above its 50-day average ($123.88) and 27.5% above its 200-day average ($110.60). It has closed above the 200-day for 86 sessions, since 7 Jul 2026. The 50-day average crossed above the 200-day on 7 Aug 2026, 62 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
RSI(14) at 71.3, 70 or above
The 14-session relative strength index closed at 71.3 on 4 Nov 2026, its 1st session at 70 or above. By convention a reading of 70 or above is called overbought and 30 or below oversold.
Daily closes, split-adjusted; Wilder's 14-session RSI · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month+13.1%

6 months+34.3%

1 year+20.4%

5 years+129.4%

Newswire

About

Website

Notable moves

August 6, 2026
+12.55%
April 25, 2025
+11.79%
July 1, 2022
−16.97%

Newswire

About

Website

Notable moves

August 6, 2026
+12.55%
April 25, 2025
+11.79%
July 1, 2022
−16.97%

Encompass Health Corporation

Encompass Health Corporation in brief

Set a 52-week high on 4 Nov 2026

Ahead of SPY, behind its sector fund XLV over 1 year

Volume 2.1× its 30-session average on 29 Oct 2026

Above its 50- and 200-day averages

RSI(14) at 71.3, 70 or above

Encompass Health Corporation

Encompass Health Corporation in brief

Set a 52-week high on 4 Nov 2026

Ahead of SPY, behind its sector fund XLV over 1 year

Volume 2.1× its 30-session average on 29 Oct 2026

Above its 50- and 200-day averages

RSI(14) at 71.3, 70 or above